Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Total Liabilities (2020 - 2026)

Biomea Fusion (BMEA) posted Total Liabilities of $27.7 million for Q1 2026, down 4.67% sequentially from $29.0 million in Q4 2025, and up 5.12% YoY from $26.3 million in Q1 2025.

Biomea Fusion (BMEA) Total Liabilities (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Total Liabilities for 7 years, with the latest figure at $27.7 million in Q1 2026.

  • Quarterly Total Liabilities rose 5.12% year-over-year to $27.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.7 million (up 5.12% YoY) and the FY2025 annual result came in at $29.0 million, up 2.31% from the prior year.
  • Total Liabilities eased to $27.7 million in Q1 2026 per BMEA's latest filing, from $29.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $45.7 million in Q2 2025 and troughed at $10.1 million in Q1 2022.
  • A 5-year average of $27.2 million and a median of $28.4 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 200.03% in 2022, then dropped 20.68% in 2025.
  • Over 5 years, Total Liabilities stood at $20.8 million in 2022, then soared by 47.78% to $30.7 million in 2023, then dropped by 7.58% to $28.4 million in 2024, then advanced by 2.31% to $29.0 million in 2025, then slipped by 4.67% to $27.7 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $27.7 million, $29.0 million, and $39.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4.20 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 4.00 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 3.22 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 10.03 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 24.74 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 24.74 Mn
Mar 31, 2026 27.67 Mn
Dec 31, 2025 29.02 Mn
Sep 30, 2025 39.57 Mn
Jun 30, 2025 45.65 Mn
Mar 31, 2025 26.32 Mn
Dec 31, 2024 28.37 Mn
Sep 30, 2024 34.45 Mn
Jun 30, 2024 32.22 Mn
Mar 31, 2024 33.18 Mn
Dec 31, 2023 30.69 Mn
Sep 30, 2023 25.48 Mn
Jun 30, 2023 24.37 Mn
Mar 31, 2023 29.51 Mn
Dec 31, 2022 20.77 Mn
Sep 30, 2022 14.42 Mn
Jun 30, 2022 11.35 Mn
Mar 31, 2022 10.10 Mn
Dec 31, 2021 6.92 Mn
Sep 30, 2021 8.07 Mn